BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19 | 0.0% | 625 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19 | -20.8% | 625 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $24 | -99.9% | 625 | 0.0% | 0.00% | -20.0% |
| Q3 2022 | $30,000 | +25.0% | 625 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $24,000 | -42.9% | 625 | -13.8% | 0.00% | -20.0% |
| Q1 2022 | $42,000 | -14.3% | 725 | +16.0% | 0.01% | 0.0% |
| Q4 2021 | $49,000 | -18.3% | 625 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $60,000 | +5.3% | 625 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $57,000 | +14.0% | 625 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $50,000 | -2.0% | 625 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $51,000 | +131.8% | 625 | -32.4% | 0.01% | +100.0% |
| Q3 2020 | $22,000 | -12.0% | 925 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $25,000 | – | 925 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |